podcasts Ratings /ratings/en/research-insights/podcasts/2020-01-21-sp-pharma-dose-pharmacy-benefit-manager-industry-in-2020-less-regulatory-overhang-expect-more-consolidations content esgSubNav
In This List

The S&P Pharma Dose - Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations

COMMENTS

A Sudden Correction To Fast-Rising U.S. Home Prices Isn't Likely

COMMENTS

COVID-19 Impact: Key Takeaways From Our Articles

RESUPD

Research Update: Australian Postal Corp. Outlook Revised To Stable On Strong Parcel Earnings; 'A+/A-1' Ratings Affirmed

What's It Worth? The Rise Of Electric Vehicles In European Auto ABS

Listen: The S&P Pharma Dose - Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations

In this episode of S&P Pharma Dose, Ji Liu, Deep Banerjee and Andy Sookram discuss the annual PBM outlook report along with their view on high-profile issuers UnitedHealth, Cigna, CVS and Rite Aid.

Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back